Disease-associated polymorphisms within the conserved ECR1 enhancer differentially regulate the tissue-specific activity of the cannabinoid-1 receptor gene promoter; implications for cannabinoid pharmacogenetics.
Human Mutation
Hay, Elizabeth A EA; Cowie, Philip P; McEwan, Andrew R AR; Ross, Ruth R; Pertwee, Roger G RG; MacKenzie, Alasdair A
Disruption of an enhancer associated with addictive behaviour within the cannabinoid receptor-1 gene suggests a possible role in alcohol intake, cannabinoid response and anxiety-related behaviour.
Psychoneuroendocrinology
Hay, Elizabeth A EA; McEwan, Andrew A; Wilson, Dana D; Barrett, Perry P; D'Agostino, Giuseppe G; Pertwee, Roger G RG; MacKenzie, Alasdair A
Contribution of Altered Endocannabinoid System to Overactive mTORC1 Signaling in Focal Cortical Dysplasia.
Frontiers In Pharmacology
García-Rincón, Daniel D; Díaz-Alonso, Javier J; Paraíso-Luna, Juan J; Ortega, Zaira Z; Aguareles, José J; de Salas-Quiroga, Adán A; Jou, Cristina C; de Prada, Inmaculada I; Martínez-Cerdeño, Verónica V; Aronica, Eleonora E; Guzmán, Manuel M; Pérez-Jiménez, María Ángeles MÁ; Galve-Roperh, Ismael I
Allele-specific differences in activity of a novel cannabinoid receptor 1 (CNR1) gene intronic enhancer in hypothalamus, dorsal root ganglia, and hippocampus.
The Journal Of Biological Chemistry
Nicoll, Gemma G; Davidson, Scott S; Shanley, Lynne L; Hing, Ben B; Lear, Marissa M; McGuffin, Peter P; Ross, Ruth R; MacKenzie, Alasdair A